Resverlogix Corp. (RVXCF)
Develops a drug to treat heart disease, kidney disease, and diabetes complications.
$0.07-0.11%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-4.4%
The outlook
RVXCF is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Analyst coverage appears thin or unavailable. The current data paints a bearish picture with limited upside signals evident in the price action.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range34% of the way from its 52-week low to high
Market cap
$21.2M
52-wk high
$0.10
52-wk low
$0.05
50-day avg
$0.07
200-day avg
$0.07
Trailing P/E
—